“Antioxidants: Beyond the Hype.” Nutrition Source. www.hsph.harvard.edu/nutritionsource/antioxidants.
Challem, Jack. The Inflammation Syndrome. Hoboken, NJ: John Wiley, 2003.
Dufault, R., B. LeBlanc, R. Schnoll, et al. “Mercury from Chlor-Alkali Plants: Measured Concentrations in Product Sugar.” Environmental Health, 2009.
Lustig, Robert H. “Sugar: The Bitter Truth.” University of California, San Francisco, video. www.youtube.com/watch?v=dBnniua6-oM.
University of California Television. www.uctv.tv/sugar-the-bitter-truth-167.
Wallinga, David, M.D., Janelle Sorensen, Pooja Mottl, and Brian Yablon, M.D. “Not So Sweet: Missing Mercury and High Fructose Corn Syrup.” Institute for Agriculture and Trade Policy, Minneapolis, Minnesota, 2009.
Web Medicine. www.webmed.com/food-recipies/features/how-antioxidants-work1.
Willett, Walter. Eat, Drink and Be Healthy. New York: Free Press, 2005.
Yang, Q., et al. “Added Sugar Intake and Cardiovascular Diseases Mortality among US Adults.” JAMA Internal Medicine 174, no. 4 (April 2014): 516–24.
Yudkin, John, and Robert H. Lustig. Pure, White, and Deadly: How Sugar Is Killing Us and What We Can Do to Stop It. New York: Penguin, 2013.
Bryan, Nathan S. “Nitric Oxide and Diabetes: The Deadly Cardiovascular Implications of Insulin Resistance.” www.integrativepractioner.com/article.aspx?id=19330.
Ducker, T. B. “Pathophysiology of Peripheral Nerve Trauma.” In G. E. Omar, ed., Management of Peripheral Nerve Problems. Philadelphia: W. B. Saunders, 1980, p. 476.
Guyuron, B., et al. “Five-Year Outcome of Surgical Treatment of Migraine Headaches.” Plastic Reconstructive Surgery 127, no. 2 (February 2011): 603–8.
Perkins, Bruce A., et al. “Carpal Tunnel Syndrome in Patients with Diabetic Polyneuropathy.” Diabetes Care 25, no. 3 (March 2002): 565–69.
Schulman, S. P., L. C. Becker, D. A. Kass, et al. “L-Arginine Therapy in Acute Myocardial Infarction: The Vascular Interaction with Age in Myocardial Infarction (VINTAGE MI) Randomized Clinical Trial.” JAMA 295, no. 1 (January 2006): 58–64.
Aszmann, O. C., K. M. Kress, and A. Dellon. “Results of Decompression of Peripheral Nerves in Diabetics: A Prospective, Blinded Study.” Plastic Reconstructive Surgery 106, no. 4 (September 2000): 816–22.
Boden, G., H. Sargrad, C. Homko, M. Mozzoli, and T. P. Stein. “Effect of a Low-Carbohydrate Diet on Appetite, Blood Glucose Levels, and Insulin Resistance in Obese Patients with Type 2 Diabetes.” Annals of Internal Medicine 142, no. 6 (March 2005): 403–11.
Chaudhry, V., J. Stevens, J. Kincaid, and Y. So. “Practice Advisory: Utility of Surgical Decompression for Treatment of Diabetic Neuropathy: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.” Neurology 66, no. 12 (2006): 1805–08.
Cooke, John. “Asymmetrical Dimethylargine: The Uber Marker?” Circulation, 2004.
Cornblath, D. R., et al. “Surgical Decompression for Diabetic Sensorimotor Polyneuropathy.” Diabetes Care 30, no. 2 (February 2007): 421–22.
Dellon, A. L. “Treatment of Symptomatic Diabetic Neuropathy by Surgical Decompression of Multiple Peripheral Nerves.” Plastic Reconstructive Surgery 89, no. 4 (April 1992): 698–99.
Dellon, A. L., V. L. Muse, D. S. Nickerson, et al. “Prevention of Ulceration, Amputation, and Reduction of Hospitalization: Outcomes of a Prospective Multicenter Trial of Tibial Neurolysis in Patients with Diabetic Neuropathy.” Journal of Reconstructive Microsurgery 28, no. 4 (2012): 241–46.
“Diabetic Neuropathy: A Small-Fiber Disease.” Medscape Multispecialty, www.medscape.org/viewarticle/418568.
Groner, C. “Nerve Decompression and Diabetic Neuropathy.” Lower Extremity Review, January 2014.
Lee, C., and A. L. Dellon. “Prognostic Ability of Tinel Sign in Determining Outcome for Decompression Surgery in Diabetic and Non-Diabetic Neuropathy.” Annals of Plastic Surgery 53 (2004): 523–27.
Nickerson, D. S., and A. J. Rader. “Low Long-Term Risk of Foot Ulcer Recurrence After Nerve Decompression in a Diabetes Neuropathy Cohort.” Journal of the American Podiatric Medicine Association. 103, no. 5 (September–October 2013): 380–86.
Malik, V. S., et al. “Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes: A Meta-Analysis.” Diabetes Care 33, no. 11 (November 2010): 2477–83.
Pecket, P., and A. Schattner. “Concurrent Bell’s Palsy and Diabetes Mellitus: A Diabetic Mononeuropathy?” Journal of Neurology Neurosurgery and Psychiatry 45, no. 7 (July 1982): 652–55.
Rydevik, B. L. “The Effects of Compression on the Physiology of Nerve Roots.” Journal of Manipulative Physiological Therapeutics 15, no. 1 (January 1992): 62–66.
Seyfried, Thomas. Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer. New York: Wiley, 2012.
Siemionow, M., M. Alghoul, M. Molski, and G. Agaoglu. “Clinical Outcome of Peripheral Nerve Decompression in Diabetic and Non-Diabetic Peripheral Neuropathy.” Annals of Plastic Surgery 57, no. 4 (2006): 385–90.
Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, V. Chaudhry, J. C. Stevens, J. Kincaid, and Y. T. So. “Practice Advisory: Utility of Surgical Decompression for Treatment of Diabetic Neuropathy.” Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 66, no. 12 (June 2006): 1805–08.
Thony, B., et al. “Tetrahydrobiopterin Biosynthesis, Regeneration, and Functions.” Biochemical Journal 374, no.1 (April 1, 2000):1–16.
Tseng, C. L., et al. “Assessing Potential Glycemic Overtreatment in Persons at Hypoglycemic Risk.” JAMA Internal Medicine 174, no. 2 (February 2014): 259–68.
Tucker, Miriam E. “Nerve Decompression Debate Continues in Diabetic Neuropathy.” Medscape, February 17, 2014. www.medscape.com/viewarticle/820691.
Upton, A. R., and A. J. McComas. “The Double Crush in Nerve Entrapment Syndromes.” Lancet 2, no. 7825 (August 18, 1973): 359–62.
Valdivia, J. M. V., et al. “Surgical Treatment of Peripheral Neuropathy: Outcomes from 100 Consecutive Decompressions.” Journal of American Podiatric Medical Association 95 (2005): 451–54.
Wieman, T. J., and V. G. Patel. “Treatment of Hyperesthetic Neuropathic Pain in Diabetics: Decompression of the Tarsal Tunnel.” Annals of Surgery 22, no. 6 (June 1995): 660–64; discussion 664–65.
Yang, Quanhe, Ph.D., et al. “Added Sugar Intake and Cardiovascular Diseases Mortality among US Adults.” JAMA Internal Medicine 174, no. 4 (2014): 516–24.
Addolorato, G., et al. “Regional Cerebral Hypoperfusion in Patients with Celiac Disease.” American Journal of Medicine 116, no. 5 (March 2004): 312–17.
American Diabetes Association. www.diabetes.org/are-you-at-risk/prediabetes/.
ALS Association. www.alsa.org/news/archive/nfl-players-risk.html.
Burke, L. M., et al. “Guidelines for Daily Carbohydrate Intake: Do Athletes Achieve Them?” Sports Medicine 31, no. 4 (2001): 267–99.
Choudhry, Oshamah, et al. “Historical Evolution of the Microvascular Decompression Procedure for Trigeminal Neuroglia: From Dandy to Jannetta.” World Science, 2012, www.world-sci.com/read.aspx?id=871.
de la Monte, Suzanne. “Alzheimer’s: Diabetes of the Brain?” Alpert Medical School, Brown University, electronic posting, April 6, 2011.
Dellon, A. L. “Susceptibility of Nerve in Diabetes to Compression: Implications for Pain Treatment.” Plastic and Reconstructive Surgery 134, no. 4S-2 (October 2014: 142S–150S.
Ford, R. P. “The Gluten Syndrome: A Neurological Disease.” Medical Hypotheses 73, no. 3 (September 2009): 438–40.
Giovannucci, E., et al. “Diabetes and Cancer: A Consensus Report.” Diabetes Care 33, no. 7 (July 2010): 1674–85.
“The Gluten Syndrome: A Neurological Disease.” www.mayoclinic.org diseases-conditions/diabetes/in-depth/blood-sugar/.
Gray, Henry. Anatomy, Descriptive and Surgical. Classic Edition. Philadelphia: Running Press, 1974.
Hassaidou, Maria. “Carbohydrate Requirements of Elite Athletes.” British Journal of Sports Medicine, 2011;45e2 doi:10,1136.
Hu, W. T., et al. “Cognitive Impairment and Celiac Disease.” Archives of Neurology 63, no. 10 (October 2006): 1440–46.
Hubbard Foundation. www.hubbardfoundation.org.
Isomaa, B., et al. “Cardiovascular Morbidity and Mortality Associated with the Metabolic Syndrome.” Diabetes Care 24, no. 4 (April 2001): 683–89.
“The Link between Diabetes and Cancer . . . and Reducing the Risk of Both.” American Institute for Cancer Research, Health@Work, November 11, 2013.
Markram, H., T. Rinaldi, and K. Markram. “The Intense World Syndrome: An Alternative Hypothesis for Autism.” Frontiers in Neuroscience 1, no. 1 (October 2007): 77–96.
Ohara, T., et al. “Glucose Tolerance Status and Risk of Dementia in the Community: The Hisayama Study.” Neurology 77, no. 12 (September 2011): 1126–34.
Pall, Martin L. Explaining “Unexplained Illnesses”: Disease Paradigm for Chronic Fatigue Syndrome, Multiple Chemical Sensitivity, Fibromyalgia, Post-Traumatic Stress Disorder, and Gulf War Syndrome. London: CRC Press, 2007.
Perry, G., et al. “Oxidative Damage in the Olfactory System in Alzheimer’s Disease.” Acta Neuropathologica 106, no. 6 (2003): 562–66.
Pinto, Jayant M., et al. “Olfactory Dysfunction Predicts 5-year Mortality in Older Adults.” PLOS-One, October 1, 2014. DCI:10,1371/journal.pone.0107541.
Rodier, Patricia M. “The Early Origins of Autism.” Scientific American, February 2000, pp. 56–63.
Rodier, P. M., et al. “Embryological Origin for Autism: Developmental Anomalies of the Cranial Nerve Motor Nuclei.” Journal of Comparative Neurology 370, no. 2 (June 1996): 247–61.
Seyfried, Thomas N., Roberto Flores, Angela M. Poff, and Dominic P. D’Agostino. “Cancer as a Metabolic Disease: Implications for Novel Therapeutics.” Carcinogenesis 35, no. 3 (March 2014): 515–27.
“Spotlight on the Gut Bacteria-Brain Connection in Autism,” November 13, 2013, www.autismspeaks.org/science/science-news.
“The Suicide Disease-Trigeminal Neuralgia or Tic Douloureux.” www.medfaxxinc.com/index.php?/Articles/the-suicide-disease-trigeminal-neuralgia-or-tic-douloureux.html.
Taubes, Gary. “Is Sugar Toxic?” New York Times Magazine, April 17, 2011, p. MM47.
Tseng, C. H. “Benign Prostatic Hyperplasia Is a Significant Risk Factor for Bladder Cancer in Diabetic Patients: A Population-Based Cohort Study Using the National Health Insurance in Taiwan.” BMC Cancer 13 (January 2013): 7.
Tullis, Paul. “A Controversial ‘Cure’ for M.S.” New York Times Magazine, October 26, 2012.
Wahls, T. L. “The Seventy Percent Solution.” Journal of General Internal Medicine 26, no. 10 (October 2011): 1215–16.
Wang, Shirley. “Key to Detecting Alzheimer’s Early Could Be in the Eye.” Wall Street Journal, July 14, 2014.
Yang, Q., et al. “Added Sugar Intake and Cardiovascular Diseases Mortality among US Adults.” JAMA Internal Medicine 174, no. 4 (April 2014): 516–24.
Zimmer, Carl. Soul Made Flesh: The Discovery of the Brain—and How It Changed the World. New York: Atria Books, 2005.
Callaghan, B. C., et al. “Triglycerides and Amputation Risk in Patients with Diabetes: Ten-Year Follow-Up in the DISTANCE Study.” Diabetes Care 34, no. 3 (March 2011): 635–40.
“Carpal Tunnel Syndrome.” American Accreditation Healthcare Commission, September 30, 2014, University of Maryland Medical Center, October 2014, http://umm.edu/health/medical/altmed/condition/carpal-tunnel-syndrome.
Choudhry, O., et al. “Historical Evolution of the Microvascular Decompression Theory for Trigeminal Neuralgia: From Dandy to Jannetta.” World Science, 2012, www.world-sci.com/read.aspx?id=871.
Danby, F. W. “Nutrition and Acne.” Clinical Dermatology 28, no. 6 (November–December 2010): 598–604.
Gill, J. M., and N. Sattar. “Fruit Juice: Just Another Sugary Drink?” Lancet Diabetes & Endocrinology 2, no. 6 (June 2014): 444–46.
Groner, C. “Nerve Decompression and Diabetic Neuropathy.” Lower Extremity Review, January 2014.
Gruber, H. J., et al. “Hyperinsulinaemia in Migraineurs Is Associated with Nitric Oxide Stress.” Cephalalgia 30, no. 5 (May 2010): 593–98.
Guyuron, B., J. S. Kriegler, J. Davis, and S. B. Amini. “Comprehensive Surgical Treatment of Migraine Headaches.” Plastic Reconstructive Surgery 115, no. 1 (January 2005): 1–9.
Hang, Yuli. “Screen for Prediabetes Using ADA Criteria for Cancer Prevention.” Diabetologia, September 8, 2014, www.diabetologia-journal.org.
Hitti, Miranda. “Carpal Tunnel May Predict Diabetes.” WebMD Health News, www.webmd.com.
“Men and Migraine.” www.themigrainetrust.org.
Merlino, G., et al. “Association of Restless Legs Syndrome in Type 2 Diabetes: A Case-Control Study.” Sleep 30, no. 7 (July 2007): 866–71.
Pfeffer, G. B., et al. “The History of Carpal Tunnel Syndrome.” Journal of Hand Surgery: British 13, no. 1 (February 1988): 28–34.
Smith, R. N., et al. “A Low-Glycemic-Load Diet Improves Symptoms in Acne Vulgaris Patients: A Randomized Controlled Trial.” American Journal of Clinical Nutrition 86, no. 1 (July 2007): 107–15.
Strauss, S. M., et al. “The Dental Office Visit as a Potential Opportunity for Diabetes Screening: An Analysis Using NHANES 2003–2004 Data.” Journal of Public Health Dentistry 70, no. 2 (Spring 2010): 156–62.
Wiggin, T. D., et al. “Elevated Triglycerides Correlate with Progression of Diabetic Neuropathy.” Diabetes 58, no. 7 (July 2009): 1634–40.
Zakrzewska, J. M., and H. Akram. “Neurosurgical Interventions for the Treatment of Classical Trigeminal Neuralgia.” Cochrane Database of Systematic Reviews, September 7, 2011, CD007312.
“Alcoholic Neuropathy.” MedlinePlus, U.S. National Library of Medicine, National Institutes of Health, www.nim.nih.gov/medlineplus/ency/article/000714.htm.
Ang, C. D., et al. “Vitamin B for Treating Peripheral Neuropathy.” Cochrane Database of Systematic Reviews 16 (July 2008): CD004573.
Brownrigg, J. R., et al. “The Association of Ulceration of the Foot with Cardiovascular and All-Cause Mortality in Patients with Diabetes: A Meta-Analysis.” Diabetologia 55, no. 11 (November 2012): 2906–12.
Bryhn, M., H. Hansteen, T. Schanche, and S. E. Aakre. “Prostaglandins, Leukotrienes and Essential Fatty Acids: The Bioavailability and Pharmacodynamics of Different Concentrations of Omega-3 Acid Ethyl Esters.” Science Direct 75, no. 1 (July 2006): 19–24.
Dibaba, D. T., et. al, “Dietary Magnesium Intake’s Role in Decreasing Metabolic Syndrome.” Diabetic Medicine, November, 2014.
Dworkin, Robert H., Ph.D., et al. “Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update.” Mayo Clinic Proceedings 85, 3 Suppl. (March 2010): S3–S14.
Forouhi, N. G., et al. “Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin resistance: The Medical Research Council Ely Prospective Study 1990-2000.” Diabetes 57 (2008): 2619–25.
Fossel, E. T. “Improvement of Temperature and Flow in Feet of Subjects with Diabetes with Use of a Transdermal Preparation of L-Arginine: A Pilot Study.” Diabetes Care 27, no. 1 (January 2004): 284–85.
Gaist, D., et al. “Statins and Risk of Polyneuropathy: A Case-Control Study.” Neurology 58, no. 0 (May 2002): 1333–37.
Halat, K. M., and C. E. Dennehy. “Botanicals and Dietary Supplements in Diabetic Peripheral Neuropathy. Journal of the American Board of Family Practice 16, no. 1 (2003): 47–57.
Hruby, Adela, et al. “Higher Magnesium Intake Reduces Risk of Impaired Glucose and Insulin Metabolism, and Progression from Prediabetes to Diabetes in Middle-Aged Americans.” Diabetes Care 37, no. 2 (February 2014): 419–27.
Kao, W. H., et al. “Serum and Dietary Magnesium and the Risk for Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities Study.” Archives of Internal Medicine 159, no. 18 (October 1999): 2151–59.
Keen, H., J. Payan, J. Allawi, et al. “Treatment of Diabetic Neuropathy with Gamma-Linolenic Acid. The Gamma-Linolenic Acid Multicenter Trial Group.” Diabetes Care 16, no. 1 (1993): 8–15.
Larsson, S. C., and A. Wolk. “Magnesium Intake and Risk of Type 2 Diabetes: A Meta-Analysis.” Journal of Internal Medicine 262, no. 2 (August 2007): 208–14.
Low, P. A., et al. “Double-Blind, Placebo-Controlled Study of the Application of Capsaicin Cream in Chronic Distal Painful Polyneuropathy.” Pain 62, no. 2 (1995): 163–68.
McNicol, E. D., A. Midbari, and E. Eisenberg. “Opioids for Neuropathic Pain.” Cochrane Database of Systematic Reviews, August 29, 2013.
Norhammar, A., et al. “Glucose Metabolism in Patients with Acute Myocardial Infarction and No Previous Diagnosis of Diabetes Mellitus: A Prospective Study.” Lancet 359, no. 9324 (June 2002): 2140–44.
Odell, Robert H., Jr. “New Device Combines Electrical Currents and Local Anesthetic for Pain Management.” Practical Pain Management 11, no. 6 (2011): 52–68.
Possidente, C. J., and R. Tandan. “A Survey of Treatment Practices in Diabetic Peripheral Neuropathy.” Primary Care Diabetes 3, no. 4 (November 2009): 253–57.
Ridker, Paul M., et al. “Cardiovascular Benefits and Diabetes Risks of Statin Therapy in Primary Prevention: An Analysis from the JUPITER Trial.” Lancet 380, no. 9841 (August 2012): 565–71.
Rodríguez-Morán, M., and F. Guerrero-Romero. “Low Serum Magnesium Levels and Foot Ulcers in Subjects with Type 2 Diabetes.” Archives of Medical Research 32, no. 4 (July–August 2001): 300–303.
Sugiyama, Takehiro, et al. “Different Time Trends of Caloric and Fat Intake Between Statin Users and Nonusers Among US Adults: Gluttony in the Time of Statins?” JAMA Internal Medicine, online, April 24, 2014, doi:10.1001/jamainternmed.2014.
Tandan, R., et al. “Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study with Long-Term Follow-Up.” Diabetes Care 15, no. 1 (1992): 8–14.
Wiffen, P. J., S. Derry, M. P. Lunn, and R. A. Moore. “Topiramate for Neuropathic Pain and Fibromyalgia in Adults.” Cochrane Database of Systematic Reviews, August 30, 2013.
Wong, Man-chun, Joanne W. Y. Chung, and Thomas K. S. Wong. “Effects of Treatments for Symptoms of Painful Diabetic Neuropathy: Systematic Review.” British Medical Journal 335, no. 7610 (July 2007): 87.
Yamanya, Abeer A., and Hayam M. Sayed. “Effect of Low Level Laser Therapy on Neurovascular Function of Diabetic Peripheral Neuropathy.” Journal of Advanced Research 3, no. 1 (January 2012): 21–28.
Zang, Kerry, et al. “Can Low-Level Laser Therapy Have an Impact for Small Fiber Neuropathy?” Podiatry Today 24, no. 6 (June 2011).
Ziegler, D., et al. “Efficacy and Safety of Antioxidant Treatment with á-Lipoic Acid over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 Trial.” Diabetes Care 34, no. 9 (September 2011): 2054–60.
Ziegler, D., et al. “Oral Treatment with Alpha-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy: The SYDNEY 2 Trial.” Diabetes Care 29, no. 11 (November 2006): 2365–70.
Zinman, Lorne H., et al. “Low-Intensity Laser Therapy for Painful Symptoms of Diabetic Sensorimotor Polyneuropathy: A Controlled Trial.” Diabetes Care 27, no. 4 (April 2004): 921–24.
Ascherio, A., et al. “Dietary Fat and Risk of Coronary Heart Disease in Men: Cohort Follow-Up Study in the United States.” British Medical Journal 313, no. 7049 (July 1996): 84–90.
Beauchamp, G. K., and P. Pearson. “Human Development and Umami Taste.” Physiology & Behavior 49, no. 5 (1991): 1009–12.
Benton, D. “Carbohydrate Ingestion, Blood Glucose, and Mood.” Neuroscience Biobehavioral Reviews 26, no. 3 (May 2002): 293–308.
Cernak, Cynthia, et al. “Combination Electrochemical Therapy (CET) to Treat Patients with Diabetic Neuropathy.” Regional Anesthesia and Pain Medicine 35, no. 5 (September/October 2010): 459–70.
Greer, Stephanie, Andrea N. Goldstein, and Matthew P. Walker. “The Impact of Sleep Deprivation on Food Desire in the Human Brain.” Nature Communications 4, no. 2259, August 6, 2013.
Kam, Katherine. “The Facts on Leptin: FAQ, the Truth About the Hormone Leptin and Obesity.” WebMD Archive, March 11, 2010, www.webmd.com/diet/features/the-facts-on-lepin-faq?page=2.
Keckeis, Marietta, et al. “Impaired Glucose Tolerance in Sleep Disorders.” PLoS One 5, no. 3 (2010): e9444.
Lennerz, Belinda S., et al. “Effects of Dietary Glycemic Index on Brain Regions Related to Reward and Craving in Men.” American Journal of Clinical Nutrition, September 2013.
Lenoir, Magalie, Fuschia Serre, et al. “Intense Sweetness Surpasses Cocaine Reward.” PLOS One, August 1, 2007, doi:10:1371/journal.pone.0000698.
Peters, John C., et al. “The Effects of Water and Non-Nutritive Sweetened Beverages on Weight Loss During a 12-Week Weight Loss Treatment Program.” Obesity, May 26, 2014, doi:10.1002/oby.20737.
Polyzos, S. A., et al. “The Potential Adverse Role of Leptin Resistance in Nonalcoholic Fatty Liver Disease: A Hypothesis Based on Critical Review of the Literature.” Journal of Clinical Gastroenterology 45, no. 1 (January 2011): 50–54.
U.S. Air Force. “Aspartame Alert.” Flying Safely, May 1992, pp. 20–21.
Beglinger, Christoph, and Lukas Degen. “Fat in the Intestine as a Regulator of Appetite: Role of CCK.” Physiology & Behavior 83 (2004): 617–21.
Boden, G., et al. “Effect of a Low-Carbohydrate Diet on Appetite, Blood Glucose Levels, and Insulin Resistance in Obese Patients with Type 2 Diabetes.” Annals of Internal Medicine 142, no. 6 (March 2005): 403–11.
Chowdhury, Rajiv, et al. “Association of Dietary, Circulating, and Supplement Fatty Acids with Coronary Risk.” Annals of Internal Medicine 160, no. 6 (March 2014): 398–406.
Geary, N. “Estradiol, CCK, and Satiation.” Peptides 22, no. 8 (August 2001): 1251–63.
Gill, J. M., and N. Sattar. “Fruit Juice: Just Another Sugary Drink?” Lancet Diabetes & Endocrinology 2, no. 6 (June 2014): 444–46.
Kasarda, D. D. “Can an Increase in Celiac Disease Be Attributed to an Increase in the Gluten Content of Wheat as a Consequence of Wheat Breeding?” Journal of Agriculture and Food Chemistry 61, no. 6 (2013): 1155–59.
Krebs-Smith, Susan M., Jill Reedy, and Claire Bosire. “Healthfulness of the U.S. Food Supply: Little Improvement Despite Decades of Dietary Guidance.” American Journal of Preventative Medicine 38, no. 5 (May 2010): 472–77.
Kris-Etherton, Penny, et al., for the Nutrition Committee Population Science Committee and Clinical Science Committee of the American Heart Association. AHA Science Advisory. Lyon Diet Heart Study. “Benefits of a Mediterranean-Style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease.” Circulation 103 (2001): 1823–25.
“Managing Your Cholesterol.” With Mason Freeman, M.D., chief of the Lipid Metabolism Unit, Massachusetts General Hospital. Harvard Health Publications, 2014, www.health.harvard.edu.
Mozaffarian, D., et al. “Trans Fatty Acids and Cardiovascular Disease.” New England Journal of Medicine 354 (2006): 1601–13.
Nestle, Marion. Food Politics: How the Food Industry Influences Nutrition and Health. Berkeley: University of California Press, 2002.
Rumawas, M. E., et al. “Magnesium Intake Is Related to Improved Insulin Homeostasis in the Framingham Offspring Cohort.” Journal of the American College of Nutrition 25, no. 6 (December 2006): 486–92.
Salas-Salvadó, J., et al. “Prevention of Diabetes with Mediterranean Diets: A Subgroup Analysis of a Randomized Trial.” Annals of Internal Medicine 160, no. 1 (January 2014): 1–10.
Siri-Tarino, Patty B., et al. “Meta-analysis of Prospective Cohort Studies Evaluating the Association of Saturated Fat with Cardiovascular Disease.” American Journal of Clinical Nutrition, January 2010.
Willett, W. C., et al. “Intake of Trans Fatty Acids and Risk of Coronary Heart Disease Among Women.” Lancet 341 (1993): 581–85.
Bazzano, L., et al. “Effects of Low-Carbohydrate and Low-Fat Diets: A Randomized Trial.” Annals of Internal Medicine 161, no. 5 (2014): 309–18.
Bhupathiraju, S. N., et al. “Changes in Coffee Intake and Subsequent Risk of Type 2 Diabetes: Three Large Cohorts of US Men and Women.” Diabetologia, April 26, 2014.
Chavarro, J. E., et al. “Soy Food and Isoflavone Intake in Relation to Semen Quality Parameters Among Men from an Infertility Clinic.” Human Reproduction, 2008, doi:10.1093/humrep/den243.
Driskell, J. A., et al. “Concentrations of Selected Vitamins and Selenium in Bison Cuts.” Journal of Animal Science 75 (1997): 2950.
Evert, A. B., et al. “Nutrition Therapy Recommendations for the Management of Adults with Diabetes.” Diabetes Care 36 (2013): 3821–42.
Fine, E. J., et al. “Targeting Insulin Inhibition as a Metabolic Therapy in Advanced Cancer: A Pilot Safety and Feasibility Dietary Trial in 10 Patients.” Nutrition 28, no. 10 (October 2012): 1028–35.
Ho, V. W., et al. “A Low Carbohydrate, High Protein Diet Slows Tumor Growth and Prevents Cancer Initiation.” Cancer Research 71, no. 13 (July 2011): 4484–93.
Ketogenic Diet Resource. www.ketogenic-diet-resource/ketoacidosis.html.
Krebs-Smith, Susan M., Patricia M. Guenther, Amy F. Subar, Sharon I. Kirkpatrick, and Kevin W. Dodd. “Americans Do Not Meet Federal Dietary Recommendations.” Journal of Nutrition 140 (2010): 1832–38.
Marchello, M. J., et al. “Nutrient Composition of Bison Fed Concentrate Diets.” Journal of Food Composition and Analysis 11 (1998): 231.
Mercola, Dr. Joseph. “The Health Dangers of Soy.” Huffington Post, August 23, 2012, http://www.huffingtonpost.com/dr-mercola/soy-health_b_1822466.html.
Mohammed, G. Abdelwahab, et al. “The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma.” PLoS ONE 7, no. 5 (2012): e36197, doi:10.1371/journal.pone.0036197.
“Otto Warburg. Biographical.” Nobelprize.org, accessed November 27, 2014.
“The Root Cause of Cancer.” www.ganodermareview.com.
Sigurdsson, Axel, M.D. “Ketosis.” Doc’s Opinion, June 2, 2014, www.docsopinion.com/2014/06/02/ketosis.
Smith, Jeffrey M. “Can Genetically-Engineered Foods Explain the Exploding Gluten Sensitivity?” Institute for Responsible Technology, 2013.
Teicholz, Nina. “What if Bad Fat Is Actually Good for You?” Men’s Health, October 10, 2007.
Thomson, Julie. “Graham Crackers Were Invented to Curb Your Sexual Desires.” Huffington Post, June 8, 2014, http://www.huffingtonpost.com/2014/08/08/graham-cracker-history-sexual-urges_n_5629961.html.
Wagh, K., et al. “Lactose Persistence and Lipid Pathway Selection in the Maasai.” PloS ONE 7, no. 9 (2012): e44751, doi:10,1371/journal.pone .0044751.
Willett, Walter C., M.D., et al. “Coffee Consumption and Coronary Heart Disease in Women.” JAMA 275, no. 6 (1996): 458–62, doi:10.1001/jama, 1996.03530300042038.